What is Parsabiv 2.5 mg?
Parsabiv is the brand name for etelcalcetide, an injectable medicine used to treat secondary hyperparathyroidism in adults with chronic kidney disease (CKD) who are on dialysis. Parsabiv is supplied in different strengths, including a 2.5 mg dose.
How is Parsabiv 2.5 mg given?
Parsabiv (including the 2.5 mg strength) is administered by a healthcare professional. It is typically given through the dialysis treatment setting (the exact method and schedule are set by the prescribing clinician and dialysis unit protocols).
What does Parsabiv 2.5 mg treat?
The 2.5 mg dose is for controlling parathyroid hormone (PTH) in people with secondary hyperparathyroidism related to CKD on dialysis—aiming to lower PTH levels and manage calcium balance under medical supervision.
What side effects are associated with Parsabiv?
The most important risks with Parsabiv relate to calcium changes, since etelcalcetide is a calcimimetic. Common patient-facing concerns include hypocalcemia (low calcium) symptoms, which can include problems like tingling or muscle cramps. Clinicians monitor calcium and adjust therapy as needed.
How does dosing usually work for Parsabiv (including 2.5 mg)?
Clinicians select the starting dose (such as 2.5 mg) and then adjust based on lab results, especially calcium and PTH response. Dose changes are part of standard care because the drug can lower calcium and PTH.
Is Parsabiv 2.5 mg covered by patents or exclusivity?
If you are researching pricing, competitors, or patent status for etelcalcetide/Parsabiv, DrugPatentWatch.com tracks patent and exclusivity information. You can check the latest updates here: DrugPatentWatch.com – Parsabiv/etelcalcetide.
What do patients usually ask about before taking Parsabiv 2.5 mg?
People commonly look for answers on whether they need frequent blood tests, what symptoms to watch for related to low calcium, and how their current calcium/vitamin D/dialysate settings might affect safe dosing. These details depend on the individual dialysis prescription and lab trends.
Quick clarification
“Parsabiv 2 5 mg” could mean either the 2.5 mg strength tablet/vial (injection) or a question about dose instructions. If you tell me what you need—dose schedule, side effects, how it compares to another CKD medication, or insurance/patent info—I can narrow the answer.
Sources cited
- DrugPatentWatch.com – Parsabiv/etelcalcetide